These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The metabolism of sialic acid in cystic fibrosis.
    Author: Ben-Yoseph Y, Defranco CL, Nadler HL.
    Journal: Pediatr Res; 1981 May; 15(5):839-42. PubMed ID: 7243384.
    Abstract:
    The activities of plasma and fibroblast cytidine 5'-monophosphate-sialic acid:glycoprotein sialyltransferases of patients with cystic fibrosis have been found to be within the range of activities of age- and sex-matched normal controls when asialofetuin served as the sialic acid acceptor. The use of desialylated preparations of purified human plasma alpha 2-macroglobulin, as an acceptor, demonstrated 35 to 52% reduction in the incorporation of sialic acid into the alpha 2-macroglobulin from patients with cystic fibrosis as compared to that of alpha 2-macroglobulin from normal controls. The reduced sialylation was dependent upon the source of the alpha 2-macroglobulin acceptor but independent of the source (cystic fibrosis or normal) of the sialyltransferase enzyme. Using radiolabeled precursors, the rates of the synthesis of N-acetylneuraminic acid from N-acetyl-D-mannosamine, the release of sialic acid from glycoproteins and the conversion of free sialic acid into CMP-sialic acid have been determined in cultured skin fibroblasts from patients with cystic fibrosis and found to be not significantly different from those of normal controls.
    [Abstract] [Full Text] [Related] [New Search]